Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P0WV
|
||||
Drug Name |
Interferon Alfa-2b
|
||||
Synonyms |
Intron A; Viraferon
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Melanoma [ICD9: 172; ICD10:C43] | Approved | [551871] | ||
Therapeutic Class |
Anticancer Agents
|
||||
Company |
Schering-plough
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H17Cl3I2N3NaO5S
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Interferon alpha 2 ligand | Target Info | Modulator | [556264] | |
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
Regulation of autophagy | |||||
PI3K-Akt signaling pathway | |||||
Toll-like receptor signaling pathway | |||||
RIG-I-like receptor signaling pathway | |||||
Cytosolic DNA-sensing pathway | |||||
Jak-STAT signaling pathway | |||||
Natural killer cell mediated cytotoxicity | |||||
Tuberculosis | |||||
Hepatitis C | |||||
Hepatitis B | |||||
Measles | |||||
Influenza A | |||||
Herpes simplex infection | |||||
Autoimmune thyroid disease | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Downstream signaling in naï | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.